TLR4 and neoplasm: In parallel, TLR4/MYD88/NF-κB signaling augments pro-inflammatory cytokines and cooperates with Wnt pathway, together reinforcing epithelial proliferation and a tumor-permissive niche (Figure 1A) (Hu et al., 2021).